C12, an attenuated, fusion delayed, very weakly hepatotropic mutant of mouse hepatitis virus strain A59 (MHV-A59) has been further characterized. We have previously shown that C12 has two amino acid substitutions relative to wild type virus in the spike protein, Q159L (within a region of S1 shown to bind to viral receptor in an in vitro assay) and H716D (in the proteolytic cleavage recognition site). We have sequenced the rest of the 31-kb genome of C12 and compared it to wild type virus. Only three additional amino acids substitutions were found, all encoded within the replicase gene. Analysis of C12 in vivo in C57Bl/6 mice has shown that despite the fact that this virus replicates in the brain to titers at least as high as wild type and causes acute encephalitis similar to wild type, this virus causes a minimal level of demyelination and only at very high levels of virus inoculation. Thus acute encephalitis is not sufficient for the induction of demyelination by MHV-A59. Analysis of mutants isolated at earlier times from the same persistently infected glial cell culture as C12, as well as mutants isolated from a second independent culture of persistently infected glial cells, suggests that both the weakly demyelinating and the weakly hepatotropic phenotypes of C12 are associated with the Q159L amino acid substitution. ᭧ 1997 Academic Press 1 Present address: Department of Molecular Virology, Baylor College tation and loss of hepatotropism was demonstrated by of Medicine, Houston, TX. the analysis of other mutants isolated from persistently 2 To whom reprint requests should be addressed. Fax: (215) 573-4858.
INTRODUCTION
for the altered pathogenic properties of the mutant viruses, we compared the sequence of the spike (S) genes The murine coronavirus, mouse hepatitis virus strain of wild type and mutant viruses isolated from persistently A59 (MHV-A59), produces both hepatitis and neurologiinfected glial cells cultures. We focused on the S protein cal disease in susceptible mice. Neurological disease because this protein mediates both binding to the viral includes both acute meningoencephalitis and chronic receptor (Holmes and Compton, 1995) and cell to cell demyelinating disease (Lavi et al., 1984b) . In vitro, MHVfusion. This, in combination with the fact that viruses A59 causes a lytic infection in mouse fibroblast cells, with mutations in the S gene have altered pathogenic but a persistent productive, nonlytic infection of primary properties (Fleming et al., 1986; Gallagher et al., 1990 ) cultured glial cells (Lavi et al., 1987) . The mechanism of suggest that S is a major determinant of viral tropism. demyelination is not well understood but it is thought to
The fusion-delayed phenotype was shown to result from involve elements of direct viral infection as well as an the substitution of an aspartic acid residue for a histidine immune mediated component (Houtman and Fleming, (H716D) in the basic sequence that serves as a recogni-1996a).
tion signal for proteolytic cleavage of the S protein (Gom-We have been using a group of MHV-A59 mutants with bold et al., 1993) . This amino acid substitution prevents altered pathogenic properties to map the determinants of cleavage of the 180-kDa precursor S protein into the two central nervous system pathogenesis and to understand approximately 90-kDa subunits, S1 and S2 (Luytjes et al., what features of infection of mice lead to demyelination. 1987; Gombold et al., 1993) . Aside from the cleavage We have previously characterized this group of attenurecognition site mutation (H716D), all the mutant viruses ated, fusion-delayed mutants, which were isolated from examined contained one, and only one, additional amino persistently infected glial cells. These mutants had acid substitution in S, Q159L, located within the amino greatly reduced ability to replicate in the liver and cause terminal portion of the S1 subunit. Analysis of fusion hepatitis (Hingley et al., 1994) . competent revertant viruses, however, showed that atten-In order to begin to identify the mutations responsible uation and loss of hepatotropism were not linked to the fusion phenotype and did not map to the H716D amino acid substitution. An association between the Q159L mu-hypothesis that this mutation may play a role in tissue fin and sectioned for staining with luxol fast blue to detect plaques indicative of demyelination. For each of five mice tropism. Interestingly, Q159L lies within the amino terminal 330 amino acids of S1, a region of the spike protein at each dose of virus, demyelination was quantitated by examining one spinal cord section (four quadrants) from demonstrated to bind to the viral receptor in an in vitro assay (Kubo et al., 1994; Suzuki and Taguchi 1996) , sug-each of five levels of spinal cord; thus there were 100 quadrants examined for each dose of virus. The experi-gesting the possibility that this amino acid may influence the interaction of the spike protein with the viral receptor.
ments were designed so that there would be five animals surviving acute infection even at high doses of virus rela-Earlier studies (see Table 1 ) also demonstrated that viruses with identical S gene sequences had different tive to the LD 50 ; however, in the case of the highest dose of C3 and all doses of B12, there were less than five virulence and hepatotropism phenotypes (Hingley et al., 1994) . Thus, to determine which additional genes may surviving animals (Figs. 2 and 3). Demyelination was also verified in the brain by staining with luxol fast blue. influence pathogenesis, we have sequenced the entire genome of the C12 mutant of MHV-A59, one of the viruses isolated from persistently infected glial cells (Gom-Genome sequencing bold et al., 1993; Hingley et al., 1994) . In addition to the two mutations found in the S gene, there were only five For sequencing of the viral genome, reverse transcriptase/polymerase chain reaction amplification (RT/ other mutations; of these, three resulted in amino acid substitutions, all within the viral replicase gene.
PCR) was carried out, using as templates, cytoplasmic RNA extracted from L2 cell monolayers infected with wild We describe here the further characterization of the C12 mutant. We have shown that despite the fact that C12 type MHV-A59, C12, C3, C5, C8, B11, or B12. Complementary DNA was synthesized using random oligomers as replicates in the brain and causes encephalitis similar to that of wild type virus, at a dose of 5000 PFUs (2 wild primers. MHV-A59-specific primers were designed to amplify fragments of about 600 base pairs. Double-type LD 50 ), at which wild type virus induces extensive demyelination in all infected animals, C12 does not in-stranded PCR products were gel purified and analyzed by automated sequencing using the Taq dye terminator duce detectable demyelination. Analysis of other mutants isolated at earlier time points from persistently infected procedure according to the manufacturer's protocol (Taq DyeDeoxy Terminator Cycle Sequencing kit, Applied Bio-glial cell cultures (Hingley et al., 1994) as well as mutants isolated from an independent culture of persistently in-systems) and the same primers used for amplification. Each fragment was sequenced in both directions. The fected glial cells, suggests that the Q159L mutation, and not the three replicase mutations, is associated with loss entire C12 genome was sequenced; fragments of each of the other viruses were sequenced as described under of the ability to demyelinate efficiently as well as the loss of the ability to induce hepatotropism.
Results.
METHODS RESULTS

Virus
Sequence comparison of the genomes of the C12 mutant and MHV-A59 MHV-A59 was obtained originally from Dr. Lawrence Sturman (Albany, NY). The mutants were plaque purified
We have shown previously that the spike (S) protein from the supernatant of either the ''C'' culture of persisencoded by the C12 mutant has two amino acid substitutently infected glial cells at 1 week (C3), 6 weeks (C5), tions as compared with the wild type S protein. Earlier 12 weeks (C8), and 16 weeks (C12) postinfection or from studies demonstrated that viruses with the identical S the independent ''B'' culture of persistently infected glial protein sequence had different virulence and hepatotropcells at 18 weeks postinfection (B11, B12) and characterism phenotypes (see Table 1 ). For example the mutant ized as previously described (Gombold et al., 1993;  Hing-B11 appeared to be blocked in its spread from the central ley et al., 1994, 1995) .
nervous system to the liver, while the mutant C12 was inhibited in its ability to replicate in hepatocytes even Demyelination when inoculated directly into the liver (Hingley et al., 1994) . The B12 mutant, while nonhepatotropic like C12, Four-to 6-week-old MHV-free C57Bl/6 mice (Jackson Laboratories, Bar Harbor, ME) were inoculated intracere-retained its virulence (Hingley et al., 1994) . Thus, we concluded that these pathogenic properties must also brally with 10-fold serial dilutions of wild type or mutant MHV-A59. At 30 days postinfection, mice surviving acute involve genes outside of S. This, in combination with the idea that it is difficult to assign phenotypes to specific infection were perfused with phosphate-buffered saline, followed by 10% buffered formalin. Brains and spinal sequences in S without knowing if there are any other mutations outside of S, led us to sequence the rest of cords were removed and tissue was embedded in paraf- with, the N protein (Fischer et al., 1997) and the hemagglutinin esterase (HE) protein, which is encoded, but not Pathogenic Phenotypes of Mutants Containing Q159L expressed in MHV-A59 (Luytjes et al., 1988 this is consistent with the notion that this protein is not essential in the MHV-A59 life cycle in vitro or in vivo a Virulence is defined by lethal dose (LD) 50 or the amount of virus (Luytjes et al., 1988) .
needed to kill half the weanling C57Bl/6 mice after intracerebral inoculation. A minus sign indicates the LD 50 is at least 2 log 10 greater than
The deduced sequences of the nonstructural proteins wild type. These data were taken from Hingley et al. (1994) .
encoded in ORFs 2a, 4, and 5a are also identical for C12 b Encephalitis is a measurement of both replication in the CNS brain and wild type virus. However, in the 21-kb sequence of and detection of viral antigen and pathology in brain sections. The data
ORF1a and ORF1b of the replicase gene of the C12 gefor WT-A59, C12, and B11 are from Hingley et al. (1994) . nome ( Fig. 1 ), there are three amino acid substitutions c Hepatitis is defined as replication and detection of viral antigen and pathology in liver sections after intrahepatic (IH) or intracerebral compared to wild type virus. There are two substitutions (IC) inoculation of mice. A minus sign indicates that virus titer was at in ORF1a (P1699S and M2196K) and one in ORF1b, least 2 log 10 less than wild type. The data for WT-A59, C12, and B11 R1330S. (The numbers are amino acid numbers starting are from Hingley et al. (1994) . from the first amino acid in each ORF.) Of the two substitutions in ORF 1a, P1699S is in the predicted papain-like proteinase-2 (PLP-2) domain; the substitution in ORF 1b, the C12 genome to identify other possible mutations that may play a role in these different pathogenicities.
R1330S, is in the predicted helicase domain (Lee et al., 1991; Bredenbeek et al., 1990; Bonilla et al., 1994) . There We have sequenced the entire 31-kb genome of C12. Sequencing was carried out by RT/PCR of viral RNA, is only one silent mutation in the genome of C12; nucleotide 2471 of ORF 1a is U rather than C, which is in the present in infected cells, as described under Materials and Methods. This generates a consensus sequence wild type genome. We have also compared the noncoding regions of C12 because it is derived from the RNA genome and not cloned cDNAs; we compared the C12 sequence with the and wild type MHV-A59. We have found no differences between C12 and wild type in the 5 or 3 noncoding published sequence for wild type A59 (from our lab as well as from other labs) (Budzilowicz et al., 1985; Budzi- regions. With the exception of the conserved intergenic region preceding the M gene, there were also no differ-lowicz and Weiss, 1987; Zoltick et al., 1990; Bonilla et al., 1994; Weiss et al., 1993; Bredenbeek et al., 1990;  Luytjes ences between C12 and wild type MHV-A59 intergenic sequences. There is one nucleotide change in the , 1988 Armstrong et al., 1983 Armstrong et al., , 1984 . Whenever we found a difference between C12 and the published tergenic region preceding the M gene. In C12 the sequence is AAUCUAAAC instead of AAUCCAAAC present MHV-A59 wild type sequence, we made a new preparation of cDNA from intracellular C12 RNA, amplified the in wild type MHV-A59 (Budzilowicz et al., 1985) . We examined the early mutants from the C culture for same double stranded DNA fragment, and verified the C12 sequence. We then determined if our wild type se-the presence of the three replicase mutations as well as the intergenic nucleotide difference. These include the quence was the same as the published one. The C12 genome had surprisingly few mutations compared to the C3, C5, and C8 mutants isolated at various times after infection (1, 6, and 12 weeks, respectively). Neither the wild type genome after 16 weeks of culture in glial cells. Figure 1 shows the comparison of the wild type and C12 replicase mutations (Table 2) nor the intergenic region mutation were present in any of the early mutants. This genomes.
With the exception of the two previously discussed suggested that these mutations arose in the culture later than either of the S mutations. amino acid substitutions in S, H716D and Q159L (Fig. 1) , there are no amino acid substitutions in the deduced In order to determine if these replicase substitutions were a general characteristic of the attenuated, tropism sequences of any of the structural proteins; this includes spike (S) (Luytjes et al., 1987; Hingley et al., 1994) , matrix mutants that arise in persistently infected glial cells, we examined the genomes of two mutants, B11 and B12, (M) (Armstrong et al., 1984) , nucleocapsid (N) (Armstrong et al., 1983) , and small membrane (E) (Budzilowicz and isolated from the independent (''B'') culture of persistently infected glial cells (Gombold et al., 1993) . None of the Weiss, 1987) proteins as well as the open reading frames (ORFs) for the I protein, encoded within, but out of frame three replicase mutations were found in either of these Lee et al. (1991) . The nonstructural, nonessential protein products of ORFs 2a, 4, and 5a are not shown. The one silent mutation (nucleotide 2471 is U rather than C, present in the wild type genome) is not shown. (B) Genes and predicted functional domains which contain these amino acid substitutions. The amino acids are numbered from the beginning of each open reading frame (ORF) (Bredenbeek et al., 1990; Bonilla et al., 1994; Luytjes et al., 1987) . The cleavage site of S was mapped by Luytjes et al. (1987) and the mapping of the receptor binding domain is from Kubo et al. (1994) . The intergenic regions are thought to be involved in transcriptional regulation (van der Most and Spaan, 1995). genomes. We then sequenced a larger region around lab (Bonilla et al., 1994; Budzilowicz et al., 1985; Budzilowicz and Weiss, 1987; Weiss et al., 1993; , the mutation in the predicted PLP-2 domain (1100 nucleotides) and the mutation in the predicted helicase domain 1990, unpublished sequences of ORF 1b). Mutations encoding amino acid substitutions included two in ORF 1a, (1800 nucleotides) to determine if there were other mutations within either of these predicted domains in B11 or two in ORF 1b, one in S, one in N, and one each in ORFs 4 and 5a. Additional silent mutations included three in B12. B11 did have another amino acid substitution within the PLP-2 domain, V1798M.
ORF 1a, two in ORF 1b, and two in N. There were also two nucleotide changes and two insertions in the 3 non-We also found several mutations, both silent and coding, in the comparison of wild type MHV-A59 that we coding region of the genome. have used to derive the mutants (obtained from Dr. L. Sturman) as compared to the published sequences Demyelination of C12 (Bredenbeek et al., 1990; Bonilla et al., 1994; Luytjes et al., 1987; Luytjes et al., 1988; Hingley et al., 1994; Arm- We have shown previously that the C12 mutant of MHV-A59 has a fusion delayed phenotype in vitro (Gom-strong et al., 1983 (Gom-strong et al., , 1984 Budzilowicz et al., 1985; Budzilowicz and Weiss, 1987; Weiss et al., 1993; Zoltick et bold et al., 1993) . Furthermore, C12 replicates to titers equal to wild type virus in the CNS and causes a similar al., 1990), some of which came from the sequencing of another MHV-A59 (obtained from Dr. J. Leibowitz) in our level of encephalitis. However, it is very weakly hepato- e Fusion was defined as previously described Gombold et al., (1993) . A negative sign signifies a delayed fusion phenotype in which fusion is negative when measured in L2 cells at 10 h postinfection but eventually does occur by about 24 h postinfection.
tropic (Hingley et al., 1994) . In an earlier study (Gombold analysis of the mutants isolated earlier from persistently infected cultures (Hingley et al., 1994) . We have used et al., 1995), we observed that C12 appeared to demyelinate strikingly less well than wild type virus. To assess the same mutants to ask whether demyelination is also associated with this mutation or perhaps with the repli-the difference in demyelination more quantitatively, we measured the amount of demyelination (as described case mutations that arise later during persistence. Thus, the C3, C5, and C8 mutants were analyzed for the ability under Materials and Methods) induced by wild type and C12 viruses as a function of dose of virus inoculated.
to induce demyelination. These results are shown in Fig.  3 and summarized in Table 2 . The C3 mutant was able Figure 2 shows these results. For wild type MHV-A59, the amount of demyelination was approximately linear to induce demyelination with the same efficiency as wild type virus, while the C5 and C8 viruses exhibit a very with the log 10 of the amount of virus inoculated. With a dose of 5000 PFU (approximately 2 LD 50 s) of wild type weakly demyelinating phenotype, similar to C12. This suggests that the demyelination phenotype correlated virus, all the animals infected had demyelination (5/5) and demyelination was present in approximately 63% of with the appearance of the Q159L mutation and before the H716D and the replicase amino acid substitutions in the spinal cord quadrants examined. We have analyzed demyelination by wild type MHV-A59 in four experiments. the evolution of the ''C'' culture. The range of demyelination was from 59 to 69% of the quadrants for a dose of 3700 to 5000 PFU; thus the DISCUSSION amount of demyelination is quite reproducible. At the We have previously shown that the group of fusion same dose C12 caused no detectable demyelination.
delayed, nonhepatotropic MHV-A59 mutants isolated Even at 100-fold higher dose of inoculation, demyelinfrom two independently infected glial cells had the same ation was observed in 3/5 of C12 infected animals and two, and only two, amino acid substitutions relative to in only 13% of the quadrants (Fig. 2) . Thus, despite the wild type in the gene encoding the spike glycoprotein S. fact that C12 replicates to high titer in the brain and
The cleavage recognition site amino acid substitution causes encephalitis to a similar extent as wild type virus (H716D) clearly correlates with the delayed fusion pheno- (Hingley et al., 1994) , it is a poor inducer of demyelination.
type, but not with loss of hepatotropism (Hingley et al., Similar results were obtained with the B11 and B12 mu-1994; Gombold et al., 1993) . The other amino acid substitants, isolated from an independent culture of persistution, Q159L, appeared to correlate with the hepatotroptently infected glial cells (Fig. 2) .
ism phenotype (Hingley et al., 1994 (Hingley et al., , 1995  see Table 2 ). We concluded this because the Q159L mutation first ap-Association of demyelination with Q159L peared in virus plaque purified from two independent persistently infected glial cell cultures at 6 weeks postin-An association between the Q159L substitution in S and the loss of hepatotropism was demonstrated by the fection, at the same time that the altered hepatotropism phenotype became evident. The H716D mutation did not esis of this virus. Since there is not yet available an infectious cDNA clone for MHV, we were not able to appear until 12 weeks postinfection, along with the delayed fusion phenotype (Hingley et al., 1994;  Table 2 ).
introduce individual mutations into the viral genome. Therefore, we used an alternative method to map muta-It was not possible to map unambiguously the hepatotropic phenotype to Q159L when the sequence of the tions that alter pathogenic properties; we sequenced the entire 31-kb genome of C12. rest of the genome was not known. Furthermore, the observation that C12, B11, and B12 have somewhat dif-Surprisingly, there were only five amino acid substitutions in the entire 31-kb genome of C12 after 16 weeks ferent pathogenic properties while possessing the same sequence of S (Table 1; Hingley et al., 1994) suggested of persistent culture in glial cells. This suggests that the fidelity of the MHV polymerase is higher than commonly that mutations outside of S must influence the pathogen- assumed (Lai, 1990; Adami et al., 1995) and/or that, dur-and for sequencing of genes 1, 2a, 4, and 5 (Bonilla et al., 1994; Budzilowicz and Weiss, 1987; Weiss et al., 1993;  ing persistence in glial cell cultures, there is a strong selective pressure against mutation within the genome. Zoltick et al., 1990) . The only amino acid substitutions in the C12 genome Consistent with this observation was our finding that, in the comparison of our MHV-A59 lab strain with the other than the two encoded in the S gene were three amino acid substitutions in the replicase gene. There are published sequences, there were just 6 amino acid substitutions and 11 silent mutations. We do not think these two amino acid substitutions encoded in ORF1a (P1699S and M2196K) and one in ORF 1b, R1330S. The P1699S sequences differences between the wild type MHV-A59 parent of C12 and the published sequences are signifi-substitution is in the predicted PLP-2 domain of ORF 1a and the R1330S substitution is in the predicted helicase cant in terms of pathogenesis. The MHV-A59 used as our wild type in these experiments (obtained from Dr. L. domain of ORF 1b (Bredenbeek et al., 1990; Lee et al., 1991 ) (see Fig. 1 ). It is difficult to predict whether the Sturman) exhibits the same pathogenic properties as the MHV-A59 (obtained from Dr. J. Leibowitz) that we used mutation in PLP-2 is likely to be significant. The B11 mutant also has a mutation, albeit a different one from for our previous pathogenesis studies (Lavi et al., 1984b) C12, V1798M in PLP-2. Numerous attempts in our lab rather than the replicase mutations. The relationship of Q159L to virulence is, however, not as clear. The obser-to detect an activity for PLP-2 had been unsuccessful, suggesting that the PLP-2 domain does not encode an vation that the B12 mutant retains its virulence (Hingley et al., 1994 , Table 1 ) demonstrates that Q159L is not active proteinase; if this were the case, then mutations in this region of the replicase gene would not be ex-sufficient for attenuation and furthermore that the loss of hepatotropism does not necessarily lead to attenuation. pected to have a phenotype. However, recently, we have found that a recombinant protein encoded in the pre-
The hepatotropic, demyelinating C3 mutant also retains its virulence while the nonhepatotropic, weakly demyelin-dicted PLP-2 domain does indeed have a proteinase activity (H. Teng and S. R. Weiss, unpublished results) .
ating C5 and C8 mutants are somewhat attenuated although probably not as attenuated as C12 (data not Thus, if PLP-2 is a necessary activity for replication, these mutations may be significant. The C12 mutation in ORF shown). Thus there may be other mutations in these viruses, absent in C12, that modify the virulence pheno-1b is in the predicted helicase domain. The recent demonstration of an ATPase activity for a recombinant protein type. The data discussed above and shown in Table 1 suggest there must be mutations outside of S that result encoded in the predicted helicase domain of ORF 1b of the human coronavirus 229E (Heusipp et al., 1997) in the differences in hepatotropism between B11 and C12, and differences in virulence between B12 and the supports the prediction that this is indeed a helicase domain. It is likely that such a polypeptide might interact other mutants. It is possible that the three replicase mutations in C12 modify the pathogenic properties. We cannot with host cell proteins and thus influence tropism. The third mutation is in ORF 1a, M2196KL, in a region of the be sure of the effects of these mutations until we can analyze recombinant viruses containing only the Q159L replicase that has not been assigned a function.
The AAUCUAAAC sequence observed preceding the mutation; such work is in progress. The mechanism of MHV induced demyelination is to M gene of C12 (different from the wild type AAUCCAAAC) is the sequence found in most of the intergenic regions this date still not well understood. There is mounting evidence that both immune mediated components as in the wild type genome (Budzilowicz et al., 1985; Bonilla et al., 1994; Luytjes et al., 1987) . Thus it is clear that this well as direct infection of virus are factors in the establishment of demyelination (Houtman and Fleming, sequence can function as an intergenic region. Since the mechanism of generation of coronavirus mRNA is still 1996a). Our observation that for wild type MHV-A59 the amount of demyelination was proportional to the log 10 of not clearly understood, the role of coronavirus conserved intergenic regions is also not known. However, it is be-the virus inoculum (Fig. 2) argues that the amount of virus in the CNS is important in the development of demyelin-lieved that intergenic regions play a role in the control of subgenomic mRNA transcription, perhaps serving as ation. This is consistent with the hypothesis that a direct infection mechanism plays a significant role in demyelin-promoters for subgenomic mRNA synthesis (van der Most and Spaan, 1995). Thus, it is possible that this ation (Houtman and Fleming, 1996a) . Alternatively, the larger virus inoculum could result in a larger number of nucleotide change could effect transcription of the C12 mRNA encoding the M gene. We doubt that this is the persistently infected cells in the CNS to be damaged by the immune response. case as the levels of M protein in cells infected with C12 is approximately the same as in wild type infected cells MHV acute infection includes encephalitis and virus replication at high titer in the CNS. It has been shown (unpublished data). While there is no evidence suggesting that any of the mutations in the C12 genome, that while infectious virus cannot be recovered from the CNS after the acute infection, viral RNA persists in the either silent or encoding amino acid substitutions, can produce a change in replication or pathogenesis by ef-white matter of the CNS probably throughout the lifetime of the mouse (Lavi et al., 1984a; Adami et al., 1995) . The fecting the secondary structure of the genome RNA, we cannot completely rule out this possibility.
group of mutants that we are working with all cause acute encephalitis, but at least in the case of the three We show here that the appearance of the Q159L mutation within the ''C'' culture of persistently infected glial that we have examined carefully (C12, B11, B12), there are only minimal levels of demyelination and only at very cells, in addition to correlating with the loss of hepatotropism, also coincides with the development of the high levels of virus inoculated. Thus encephalitis does not necessarily lead to demyelination. Several other labs weakly demyelinating phenotype. Further evidence that the Q159L mutation is important in the demyelination have reported mutants of the JHM strain of MHV, in which encephalitis and demyelination are dissociated. For ex-phenotype comes from our observations that the B11 and B12 mutants, isolated from another parallel glial cell ample the attenuated JHM2.2-V-1 mutant (Fleming et al., 1986 (Fleming et al., , 1987 and the MHV-4 mutant 5A13.5 mutant (Dalziel culture, are also weakly demyelinating (Fig. 2) and contain this mutation in the S gene (Hingley et al., 1994 (Hingley et al., ). et al., 1986 Fazakerley et al., 1992) cause little encephalitis but do induce significant demyelinating disease. Both Thus it appears that the demyelination and hepatotropism phenotypes of C12 are both associated with Q159L, of these mutants were selected by resistance to mono-clonal antibodies directed against epitopes in the S gene; to a change in viral tropism, perhaps through receptor utilization. thus, the change in pathogenic phenotype is likely to
We are currently using targeted recombination techmap to S. The mutants we have selected from persisnology developed by Dr. Paul Masters (Masters et al., tently infected glial cells (C12, B11, and B12 for example) Fischer et al., 1997) to introduce Q159L alone into are, to our knowledge, the first examples of MHV mutants the genome of wild type MHV-A59. This will allow us to in which encephalitis occurs without subsequent demyedetermine unambiguously the effects of this amino acid linating disease.
substitution alone on pathogenesis and interaction of the The location of the Q159L amino acid substitution mutant protein with the MHV receptor. within the predicted receptor binding domain (Kubo et al., 1994) of S suggests that this mutation may play a ACKNOWLEDGMENTS role in the development of demyelination and hepatitis by affecting the interaction of S and the viral receptor. This work was supported by public health service Grants NS-21954 The inability of C12 to interact with the receptor on one (S.R.W.) and NS-30606 (S.R.W.) as well as Grants RG-2585A4/1 (S.R.W.) and RG-26151/2 (E.L.) from the National Multiple Sclerosis Society. We or more liver cell types would be a reasonable explanathank Drs. Julian Leibowitz and Henry Teng for reading and commenttion for the lack of hepatitis following infection with C12.
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